143 related articles for article (PubMed ID: 25920563)
21. Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of tumor growth and tumor angiogenesis of mouse ehrlich ascites tumor in vivo.
Kumar CS; Chandru H; Sharada AC; Thimmegowda NR; Prasad SB; Kumar MK; Rangappa KS
Med Chem; 2008 Sep; 4(5):466-72. PubMed ID: 18782043
[TBL] [Abstract][Full Text] [Related]
22. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and antiangiogenic activity of grandisin.
Valadares MC; de Carvalho IC; de Oliveira Junior L; Vieira Mde S; Benfica PL; de Carvalho FS; Andrade LV; Lima EM; Kato MJ
J Pharm Pharmacol; 2009 Dec; 61(12):1709-14. PubMed ID: 19958595
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo.
Anand K; Sarkar A; Kumar A; Ambasta RK; Kumar P
Nutr Cancer; 2012; 64(5):714-24. PubMed ID: 22642894
[TBL] [Abstract][Full Text] [Related]
25. The ponatinib/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation/angiogenesis.
El-Lakkany NM; Elkattan HH; Elsisi AE
Toxicol Appl Pharmacol; 2021 Dec; 432():115767. PubMed ID: 34699866
[TBL] [Abstract][Full Text] [Related]
26. CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Ruffilli I; Di Domenicantonio A; Fioravanti A; Sartini S; Minuto M; Piaggi S; Corti A; Alì G; Di Desidero T; Berti P; Fontanini G; Danesi R; Da Settimo F; Miccoli P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E528-36. PubMed ID: 22278419
[TBL] [Abstract][Full Text] [Related]
27. N-Substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo.
Kumar CA; Swamy SN; Gaonkar SL; Basappa ; Salimath BP; Rangappa KS
Med Chem; 2007 May; 3(3):269-76. PubMed ID: 17504198
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
29. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma.
Hazem RM; Mohamed AA; Ghareb N; Mehanna ET; Mesbah NM; Abo-Elmatty DM; Elgawish MS
Eur J Pharmacol; 2021 Feb; 892():173747. PubMed ID: 33232730
[TBL] [Abstract][Full Text] [Related]
30. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
31. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
32. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
33. Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-B and its DNA binding activity.
Thippeswamy G; Sheela ML; Salimath BP
Eur J Pharmacol; 2008 Jul; 588(2-3):141-50. PubMed ID: 18513715
[TBL] [Abstract][Full Text] [Related]
34. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
35. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra.
Sheela ML; Ramakrishna MK; Salimath BP
Int Immunopharmacol; 2006 Mar; 6(3):494-8. PubMed ID: 16428085
[TBL] [Abstract][Full Text] [Related]
38. In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor.
Chandru H; Sharada AC; Bettadaiah BK; Kumar CS; Rangappa KS; Sunila ; Jayashree K
Bioorg Med Chem; 2007 Dec; 15(24):7696-703. PubMed ID: 17869527
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
40. 3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.
Rakesh KS; Jagadish S; Balaji KS; Zameer F; Swaroop TR; Mohan CD; Jayarama S; Rangappa KS
Inflammation; 2016 Feb; 39(1):269-280. PubMed ID: 26363638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
